References
- Bartlett JG. Clostridium difficile: clinical considerations. Rev Infect Dis 1990; 12: S243–51.
- Kelly CP, Pothoulakis C, Lamont JT. Clostridium difficile colitis. New Engl J Med 1994; 330: 257–62.
- Lyerly DM, Krivan H, Wilkins T. Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1998; 1: 1–18.
- Allen SD, Emery CL, Siders JA. Clostridium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology. 7th ed. Washington, DC: ASM Press, 1999; 654–71.
- Oxoid Limited. Oxoid Toxin Detection Kits. C. difficile Toxin A Test. Basingstoke: Oxoid Limited, 2000.
- Medvet Science Pty Ltd. Serobact C. difficile Latex Slide Agglutina-tion Test. Adelaide: Medvet Science, 2000.
- Techlab. Clostridium difficile Toxin/Antitoxin Kit. Blacksburg, VA: Techlab, 2000.
- Barbut F, Corthier G, Charpak Y, et al. Prevalence and pathogenicity of Clostridium difficile in hospitalised patients. Arch Intern Med 1996; 156: 1449–54.
- Riley TV, O'Neill GL, Bowman RA, Golledge CL. Clostridium difficile-associated diarrhoea; epidemiological data from Western Australia. Epidemiol Infect 1994; 113: 13–20.
- Staneck JL, Weckbach LS, Allen SD, et al. Multicenter evaluation of four methods for Clostridium difficile detection: Immunocard C. difficile, cytotoxin assay, culture and latex agglutination. J Clin Microbiol 1996; 34: 2718–21.
- Peterson LR, Kelly PJ, Nordbrock HA. Role of culture and toxin detection in laboratory testing for diagnosis of Clostridium difficile-associated diarrhea. Eur J Clin Microbiol Infect Dis 1996; 15: 330–6.
- O'Connor RD, Hynes P, Cormican M, Collins E, Corbett-Feeney G, Cassidy M. Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhoea. J Clin Microbiol 2001; 39: 2846–9.
- Fille M, Larcher C, Dierich MP, Allerberger F. Evaluation of four methods for detection of Clostridium difficile or C. difficile toxin: cyto-toxin assay, culture, latex agglutination and a new rapid immunoassay (C. difficile toxin A test). Z Gastroenterol 1998; 36: 143–9.
- Bentley AH, Patel NB, Sidorczuk M, et al. Multicentre evaluation of a commercial test for the rapid diagnosis of Clostridium difficile-mediated antibiotic-associated diarrhoea. Eur J Clin Microbiol Infect Dis 1998; 17: 788–90.
- Vanpoucke H, De Baere T, Claeys G, Vaneechoutte M, Verschraegen G. Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens. Clin Microbiol Infect 2001; 7: 55–64.
- Patel JB, Donahue AM, Nachamkin I. Performance of two rapid, single-use immunoassays for the detection of Clostridium difficile toxin A. Diagn Microbiol Infect Dis 2001; 39: 21–4.
- Schue V, Green GA, Monteil H. Comparison of the ToxA test with cytotoxicity assay and culture for the detection of Clostridium difficile-associated diarrhoea disease. J Med Microbiol 1994; 41: 316–8.
- Sambol SP, Merrigan MM, Lyerly D, Gerding DN, Johnson S. Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease. Infect Immunol 2000; 68: 5480–7.
- Alfa MJ, Kabani A, Lyerly D, et al. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium diffici/e-associated diarrhoea. J Clin Microbiol 2000; 38: 2706–14.
- Barbut F, Lalande V, Burghoffer B, Thien HV, Grimprel E, Petit J. Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J Clin Microbiol 2002; 40: 2079–83.